$Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)$

PremiumPress Releases

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)

5M ago

AFMD

PremiumPress Releases

Affimed Announces Positive Data for AFM24 in Combination with the PD-L1 Checkpoint Inhibitor Atezolizumab in Heavily Pre-treated EGFR-Wildtype Non-Small Cell Lung Cancer Patients

5M ago

AFMD

PremiumPress Releases

Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24

5M ago

AFMD

PremiumPress Releases

Affimed Reports Third Quarter 2023 Financial Results and Highlights Operational Progress

6M ago

AFMD

More AFMD News >

A28 News on the Web

2024-03-08

ASTR Stock Alert: Astra Space Is Going Private

InvestorPlace

Neutral

2024-03-08

Why Is AerSale (ASLE) Stock Down 18% Today?

InvestorPlace

Neutral

2024-03-08

Why Is Affimed (AFMD) Stock Moving Today?

InvestorPlace

Neutral

2024-03-08

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Friday

InvestorPlace

Neutral

2024-03-06

7 of the Best Speculative Stocks You Can Snag for Less Than $1

InvestorPlace

Neutral

2024-03-06

Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday

InvestorPlace

Neutral

2024-03-06

Affimed announces 1-for-10 reverse stock split

Investing.com

Bullish

2024-03-06

Affimed announces 1-for-10 reverse stock split

Investing.com

Bullish

News Score - Last 7 Days

Neutral

DE:A28

Sector Average

Media Buzz

This Week4 articles

Weekly Average2.75 articles

News Sentiment

This Week50%

Sector Average62%

See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is DE:A28’s Media Buzz Sentiment?

4 articles about DE:A28 were published this week. In an average week, 2.75 articles are published.

What is DE:A28’s weekly average amount of articles?

In an average week, 2.75 articles about DE:A28 are published.

What is DE:A28’s News Sentiment?

50% of articles about DE:A28 were positive this week, compared to its sector average of 62%.

Healthcare Stocks that are Trending in the News

RGLSRegulus

SIGASIGA Technologies

BVSBioventus

SONNSonnet BioTherapeutics Holdings

APREAprea Therapeutics

Showing the stocks with the most bullish news sentiment over the past week

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing